Supriya Lifescience: Dividend Taxation Provisions Explained to Shareholders

Supriya Lifescience Ltd has issued an email communication to its shareholders detailing the dividend taxation provisions as per the Income Tax Act, 1961. The company will deduct tax at source (TDS) on the recommended final dividend of Re. 1.00 per equity share for FY 2025-26, subject to shareholder approval. The TDS rates will vary based on the shareholder's residential status and submitted documentation. Resident individual shareholders with aggregate dividend income not exceeding ₹10,000 will be exempt. Shareholders are urged to update their details with the RTA for accurate tax deduction.